Cyclophosphamide and Dermatitis exfoliative - a phase IV clinical study of FDA data
We study 169,775 people who have side effects when taking Cyclophosphamide. Dermatitis exfoliative is found, especially among people who are male, 60+ old, have been taking the drug for < 1 month, also take Prednisone and have Acute lymphocytic leukemia (all).
The phase IV clinical study analyzes which people take Cyclophosphamide and have Dermatitis exfoliative. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
169,775 people reported to have side effects when taking Cyclophosphamide.
Among them, 118 people (0.07%) have Dermatitis exfoliative.
What is Cyclophosphamide?
Cyclophosphamide has active ingredients of cyclophosphamide. It is used in multiple myeloma. Currently, eHealthMe is studying from 169,918 Cyclophosphamide users.
What is Dermatitis exfoliative?
Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss) is found to be associated with 1,454 drugs and 932 conditions by eHealthMe. Currently, we are studying 6,486 people who have Dermatitis exfoliative.
Number of Cyclophosphamide and Dermatitis exfoliative reports submitted per year:
Time on Cyclophosphamide when people have Dermatitis exfoliative *:
Gender of people who have Dermatitis exfoliative when taking Cyclophosphamide*:
Age of people who have Dermatitis exfoliative when taking Cyclophosphamide *:
Common drugs people take besides Cyclophosphamide *:
Common side effects people have besides Dermatitis exfoliative *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Cyclophosphamide and have Dermatitis exfoliative?Check whether Dermatitis exfoliative is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
Cyclophosphamide side effects by duration, gender and age:
- Cyclophosphamide side effects (169,918 reports)
Dermatitis exfoliative treatments and more:
- Dermatitis exfoliative (6,486 reports)
Common drugs associated with Dermatitis exfoliative:
- Renova: 646 reports
- Allopurinol: 455 reports
- Lopurin: 454 reports
- Furosemide: 346 reports
- Prednisone: 324 reports
- Aspirin: 318 reports
- Lasix: 303 reports
- Omeprazole: 285 reports
- Bactrim: 256 reports
- Methotrexate: 241 reports
All the drugs that are associated with Dermatitis exfoliative:
- Dermatitis exfoliative (1,454 drugs)
Common conditions associated with Dermatitis exfoliative:
- High blood pressure: 405 reports
- Psoriasis: 378 reports
- Epilepsy: 185 reports
- Preventive health care: 168 reports
- Pain: 153 reports
- Hiv infection: 141 reports
All the conditions that are associated with Dermatitis exfoliative:
- Dermatitis exfoliative (932 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on cyclophosphamide (the active ingredients of Cyclophosphamide) and Cyclophosphamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Neupogen and Burkitt Lymphoma - 6 seconds ago
- Bactrim and Arthritis - 6 seconds ago
- Benadryl and Tenofovir Disoproxil Fumarate drug interaction - 9 seconds ago
- Metolazone and Empliciti drug interaction - 15 seconds ago
- How effective is Bactrim Ds for Hiv Infection? - 33 seconds ago
- Rinvoq and Urinary Tract Infection - 42 seconds ago
- Minipress and Prednisone drug interaction - 44 seconds ago
- Erythromycin Stearate and Elidel drug interaction - 51 seconds ago
- Sprintec and Yaz drug interaction - 58 seconds ago
- Lisinopril and Actinic Keratosis - a minute ago